These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29724722)

  • 1. Coronary Artery Remodeling and Fibrosis With Continuous-Flow Left Ventricular Assist Device Support.
    Ambardekar AV; Weiser-Evans MCM; Li M; Purohit SN; Aftab M; Reece TB; Moulton KS
    Circ Heart Fail; 2018 May; 11(5):e004491. PubMed ID: 29724722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Continuous-Flow Left Ventricular Assist Device Support on Coronary Artery Endothelial Function in Ischemic and Nonischemic Cardiomyopathy.
    Symons JD; Deeter L; Deeter N; Bonn T; Cho JM; Ferrin P; McCreath L; Diakos NA; Taleb I; Alharethi R; McKellar S; Wever-Pinzon O; Navankasattusas S; Selzman CH; Fang JC; Drakos SG
    Circ Heart Fail; 2019 Aug; 12(8):e006085. PubMed ID: 31422672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Aortic Wall Structure, Composition, and Stiffness With Continuous-Flow Left Ventricular Assist Devices: A Pilot Study.
    Ambardekar AV; Hunter KS; Babu AN; Tuder RM; Dodson RB; Lindenfeld J
    Circ Heart Fail; 2015 Sep; 8(5):944-52. PubMed ID: 26136459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic Changes in Aortic Vascular Stiffness in Patients Bridged to Transplant With Continuous-Flow Left Ventricular Assist Devices.
    Patel AC; Dodson RB; Cornwell WK; Hunter KS; Cleveland JC; Brieke A; Lindenfeld J; Ambardekar AV
    JACC Heart Fail; 2017 Jun; 5(6):449-459. PubMed ID: 28285118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous-Flow Left Ventricular Assist Device Support Improves Myocardial Supply:Demand in Chronic Heart Failure.
    Soucy KG; Bartoli CR; Phillips D; Giridharan GA; Sobieski MA; Wead WB; Dowling RD; Wu ZJ; Prabhu SD; Slaughter MS; Koenig SC
    Ann Biomed Eng; 2017 Jun; 45(6):1475-1486. PubMed ID: 28168379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix-Degrading Enzyme Expression and Aortic Fibrosis During Continuous-Flow Left Ventricular Mechanical Support.
    Ambardekar AV; Stratton MS; Dobrinskikh E; Hunter KS; Tatman PD; Lemieux ME; Cleveland JC; Tuder RM; Weiser-Evans MCM; Moulton KS; McKinsey TA
    J Am Coll Cardiol; 2021 Nov; 78(18):1782-1795. PubMed ID: 34711337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Cerebral Flow Autoregulation Function on Cerebral Flow Rate Under Continuous Flow Left Ventricular Assist Device Support.
    Bozkurt S
    Artif Organs; 2018 Aug; 42(8):800-813. PubMed ID: 29726017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
    Mastrobuoni S; Dell'Aquila AM; Van Caenegem O; Poncelet A; Jacquet LM; Garcia J
    Transplantation; 2018 Jun; 102(6):e288-e294. PubMed ID: 29346259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support.
    Lok SI; Nous FM; van Kuik J; van der Weide P; Winkens B; Kemperman H; Huisman A; Lahpor JR; de Weger RA; de Jonge N
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):407-15. PubMed ID: 25609773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Continuous-Flow Mechanical Circulatory Support on Microvasculature Remodeling in the Failing Heart.
    Saito T; Miyagawa S; Toda K; Yoshikawa Y; Fukushima S; Saito S; Yoshioka D; Sakata Y; Daimon T; Sawa Y
    Artif Organs; 2019 Apr; 43(4):350-362. PubMed ID: 30129970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a single-arm prospective study.
    Patel SR; Saeed O; Murthy S; Bhatia V; Shin JJ; Wang D; Negassa A; Pullman J; Goldstein DJ; Maybaum S
    J Heart Lung Transplant; 2013 Mar; 32(3):305-12. PubMed ID: 23415314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic changes in the aortic wall media after support with a continuous-flow left ventricular assist device.
    Segura AM; Gregoric I; Radovancevic R; Demirozu ZT; Buja LM; Frazier OH
    J Heart Lung Transplant; 2013 Nov; 32(11):1096-100. PubMed ID: 23968812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving arterial pulsatility by feedback control of a continuous flow left ventricular assist device via in silico modeling.
    Bozkurt S; van de Vosse FN; Rutten MC
    Int J Artif Organs; 2014 Oct; 37(10):773-85. PubMed ID: 24970558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraplatelet reactive oxygen species, mitochondrial damage and platelet apoptosis augment non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist device.
    Mondal NK; Sorensen EN; Hiivala NJ; Feller ED; Pham SM; Griffith BP; Wu ZJ
    Platelets; 2015; 26(6):536-44. PubMed ID: 25167344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of impaired myocardial beta-adrenergic receptor signaling by continuous-flow left ventricular assist device support.
    Akhter SA; D'Souza KM; Malhotra R; Staron ML; Valeroso TB; Fedson SE; Anderson AS; Raman J; Jeevanandam V
    J Heart Lung Transplant; 2010 Jun; 29(6):603-9. PubMed ID: 20202864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of continuous flow left ventricular assist device support on microvascular endothelial function.
    Lou X; Templeton DL; John R; Dengel DR
    J Cardiovasc Transl Res; 2012 Jun; 5(3):345-50. PubMed ID: 21932132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Physiological Rationale for Incorporating Pulsatility in Continuous-Flow Left Ventricular Assist Devices.
    Grosman-Rimon L; Billia F; Kobulnik J; Pollock Bar-Ziv S; Cherney DZ; Rao V
    Cardiol Rev; 2018; 26(6):294-301. PubMed ID: 29608506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Left Ventricular Unloading by Pump Speed Adjustment on Myocardial Flow in Continuous-flow Left Ventricular Assist Device Patients.
    Yuzefpolskaya M; Ladanyi A; Bokhari S; Jorde UP; Colombo PC
    ASAIO J; 2023 May; 69(5):460-466. PubMed ID: 36516021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.